185 related articles for article (PubMed ID: 7285618)
41. Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group.
Lamberg SI; Green SB; Byar DP; Block JB; Clendenning WE; Epstein EH; Fuks ZY; Golitz LE; Lorincz AL; Michel B; Roenigk HH; Van Scott EJ; Vonderheid EC; Thomas RJ
Cancer Treat Rep; 1979 Apr; 63(4):701-7. PubMed ID: 376140
[TBL] [Abstract][Full Text] [Related]
42. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups.
Sausville EA; Eddy JL; Makuch RW; Fischmann AB; Schechter GP; Matthews M; Glatstein E; Ihde DC; Kaye F; Veach SR
Ann Intern Med; 1988 Sep; 109(5):372-82. PubMed ID: 3408055
[TBL] [Abstract][Full Text] [Related]
43. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
44. Thymic localization of erythrodermic cutaneous T-cell lymphoma.
Bonnet P; Battistella M; Bouaziz JD; Ram-Wolff C; Frumholtz L; Herms F; Clerc G; Bonhomme A; Brice P; Bagot M; de Masson A
Br J Dermatol; 2019 Feb; 180(2):427-428. PubMed ID: 30339741
[No Abstract] [Full Text] [Related]
45. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
[TBL] [Abstract][Full Text] [Related]
46. A new nail in the CTCL coffin.
Lessin SR
J Invest Dermatol; 2006 Nov; 126(11):2368-9. PubMed ID: 17041618
[TBL] [Abstract][Full Text] [Related]
47. [Item no 164: malignant lymphoma: cutaneous lymphoma].
CEDEF
Ann Dermatol Venereol; 2008 Nov; 135(11 Suppl):F160-2. PubMed ID: 18984207
[No Abstract] [Full Text] [Related]
48. [Annular erythema in a 78-year old woman].
Booken N; Utikal J; Hildenbrand R; Goerdt S; Klemke CD
J Dtsch Dermatol Ges; 2008 Apr; 6(4):321-3. PubMed ID: 18377564
[No Abstract] [Full Text] [Related]
49. Cutaneous T-cell lymphomas. A review of the recent literature.
Zackheim HS
Arch Dermatol; 1981 May; 117(5):295-304. PubMed ID: 6971626
[TBL] [Abstract][Full Text] [Related]
50. Cytokine signaling pathways as molecular markers of the efficacy of phototherapy in early stages of mycosis fungoides.
Vorontsova AA; Karamova AE; Nikonorov AA; Kozlova IV; Nikonorova ER; Kubanov AA
Arch Dermatol Res; 2024 Apr; 316(5):127. PubMed ID: 38662241
[No Abstract] [Full Text] [Related]
51. Mycosis fungoides: time to define the best therapy.
Kuzel TM; Springer E; Roenigk HH; Rosen ST
J Natl Cancer Inst; 1990 Feb; 82(3):183-5. PubMed ID: 1688623
[No Abstract] [Full Text] [Related]
52. Mycosis fungoides and the Sézary syndrome.
Gisselbrecht C; Dubertret L
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):73-5. PubMed ID: 8511044
[No Abstract] [Full Text] [Related]
53. Problems in histological diagnosis of mycosis fungoides.
Civatte J; Kapetis E
Bull Cancer; 1977; 64(2):187-90. PubMed ID: 912129
[No Abstract] [Full Text] [Related]
54. Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers.
Hughes CF; Newland K; McCormack C; Lade S; Prince HM
Australas J Dermatol; 2016 Aug; 57(3):182-91. PubMed ID: 25988337
[TBL] [Abstract][Full Text] [Related]
55. Mycosis fungoides: clinical features and management.
Blaylock WK
Prog Clin Biol Res; 1978; 25():149-56. PubMed ID: 310557
[No Abstract] [Full Text] [Related]
56. Antithymocyte globulin in the management of cutaneous T cell lymphoma.
Edelson RL; Raafat J; Berger CL; Grossman M; Troyer C; Hardy M
Cancer Treat Rep; 1979 Apr; 63(4):675-80. PubMed ID: 312698
[TBL] [Abstract][Full Text] [Related]
57. [Clinical, histological and immunohistochemical study of the early diagnosis of mycosis fungoides].
Goos M; Eckstein M; Biskup K
Z Hautkr; 1983 Mar; 58(6):373-84. PubMed ID: 6845804
[No Abstract] [Full Text] [Related]
58. Increased 2',5'-oligoadenylate synthetase activity in blood mononuclear leukocytes from patients with advanced cutaneous T-cell lymphoma.
Vonderheid EC; Suhadolnik RJ; Sobel EL; Flick MB; Mosca JD
Clin Immunol Immunopathol; 1984 Apr; 31(1):138-50. PubMed ID: 6199147
[TBL] [Abstract][Full Text] [Related]
59. Circulating CD4+CD7- lymphocyte burden and rapidity of response: predictors of outcome in the treatment of Sézary syndrome and erythrodermic mycosis fungoides with extracorporeal photopheresis.
Stevens SR; Baron ED; Masten S; Cooper KD
Arch Dermatol; 2002 Oct; 138(10):1347-50. PubMed ID: 12374541
[TBL] [Abstract][Full Text] [Related]
60. Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy.
Kuzel TM; Roenigk HH; Rosen ST
J Clin Oncol; 1991 Jul; 9(7):1298-313. PubMed ID: 2045869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
